Table 4 Comparison of the biochemical parameters between different ApoE alleles in hyperuricemia patients and controls

control group

BUN (mg/dl)

5.15 ± 1.42

5.23 ± 1.46

5.30 ± 1.44

5.22 ± 1.45

0.675

0.682

0.516

Cr (mg/dl)

75.54 ± 15.60

76.99 ± 18.88

80.53 ± 16.74

77.36 ± 18.12

0.523

0.107

0.080

SUA (mmol/L)

287.93 ± 57.89

312.24 ± 59.89

311.86 ± 61.03

308.54 ± 60.30

0.001*

0.958

0.011*

FBS(mmol/L)

5.29 ± 1.35

5.19 ± 1.18

5.03 ± 0.82

5.18 ± 1.16

0.480

0.260

0.149

TG(mmol/L)

2.13 ± 1.52

2.58 ± 1.8

2.29 ± 1.59

2.46 ± 1.77

0.037*

0.188

0.578

TC(mmol/L)

4.17 ± 1.38

4.20 ± 1.50

4.15 ± 1.54

4.19 ± 1.48

0.863

0.791

0.936

HDL-C(mmol/L)

1.14 ± 0.44

1.22 ± 0.45

1.20 ± 0.34

1.20 ± 0.44

0.158

0.825

0.364

LDL-C(mmol/L)

2.45 ± 0.63

2.81 ± 0.82

2.78 ± 0.67

2.75 ± 0.78

0.000*

0.710

0.008*

Groups

Variable(s)

ApoE2 (45)

ApoE3 (359)

ApoE4 (59)

Total (463)

p ^a

p ^b

p ^c

BUN (mg/dl)

5.74 ± 2.29

6.51 ± 3.44

6.20 ± 2.16

6.39 ± 3.21

0.135

0.503

0.470

Cr (mg/dl)

79.64 ± 30.99

87.13 ± 25.21

90.17 ± 37.16

88.76 ± 35.37

0.060

0.540

0.285

Hyperuricemia patients

SUA (mmol/L)

473.29 ± 55.02

476.53 ± 71.12

500.82 ± 85.37

494.95 ± 81.42

0.840

0.058*

0.016*

FBS(mmol/L)

5.38 ± 2.07

5.39 ± 1.69

5.39 ± 2.17

5.39 ± 1.79

0.938

0.999

0.950

TG(mmol/L)

2.44 ± 1.13

2.77 ± 1.0

2.71 ± 1.4259

2.73 ± 1.53

0.168

0.775

0.369

TC(mmol/L)

4.29 ± 1.54

4.16 ± 1.39

4.54 ± 1.21

4.22 ± 1.39

0.532

0.047*

0.363

HDL-C(mmol/L)

1.23 ± 0.87

1.12 ± 0.55

1.14 ± 0.64

1.13 ± 0.60

0.221

0.810

0.419

LDL-C(mmol/L)

2.33 ± 1.00

2.71 ± 0.82

2.72 ± 1.00

2.67 ± 0.87

0.006*

0.929

0.023*